growth · preclinical
CJC-1295 (no DAC)
Análogo GHRH modificado.
Status:preclinical
Updated:May 13, 2026
Contributors:1
Half-life
0.5 h
Routes
SC
Typical dose
100–200 mcg
Mechanism of action
Estimula secreção pulsátil natural de GH.
Reported applications
- · GH pulsatility
Frequently asked
What is CJC-1295 (no DAC)?
Análogo GHRH modificado.
What is the half-life of CJC-1295 (no DAC)?
Reference half-life: approximately 0.5 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing CJC-1295 (no DAC)?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.
